Global Unnatural Amino Acids Market Size, Share, Forecast Report, 2020-2027

Global Unnatural Amino Acids Market was valued at USD 4,851.13 Million in 2019 and is expected to register a CAGR of 8.21% during the forecast period of 2020 to 2027.

Unnatural or unusual amino acids are non-proteinogenic amino acids which can occur naturally in plant and bacteria post-translationally or are chemically synthesized. They are used to increase the activity and plasma stability of peptides in drug discovery and development.

The global unnatural amino acids market is mainly driven by the increasing prevalence of chronic disorders. For instance, according to the Bright Focus Foundation, more than 5.8 million Americans in 2018 had Alzheimer's disease and by 2050, nearly 14 million (13.8 million) Americans over age 65 could be living with the disease. Moreover, the rising applications of amino acids in pharmaceutical applications and growing pharmaceutical industry are expected to drive the market growth. However, the stringent government regulations and the impact of COVID-19 on demand and supply chain are likely to hamper the market growth.
Segmentation

Global Unnatural Amino Acids Market has been divided based on Type, Application and End User.

The market, based on Type, has been segregated into D-amino acids & derivatives, DL-amino acids & derivatives, β-amino acids & derivatives, cyclic amino acids & derivatives, L-amino acid derivatives, gamma-aminobutyric acid {GABA}, gamma-amino-beta-hydroxybutyric acid {GABOB}, synthetic-amino acids, and others.

On the basis of application, the market is bifurcated into liver diseases, cancer, inflammatory disease, genetic diseases, and others.

On the basis of end user, the market is bifurcated into pharmaceutical & biotechnological companies, research laboratories, academic institutes, and others.
Key Players

The prominent players in the Global Unnatural Amino Acids Market are Merck KGaA (Germany), Ajinomoto Co., Inc. (Japan), BASF SE (Switzerland), Enzo Life Sciences, Inc. (US), AminoLogics Co., Ltd (South Korea), AnaSpec, Inc. (US), Hanhong Scientific (China), Bio-Techne Corporation (US), Tokyo Chemical Industry Co., Ltd (Japan), and Yoneyama Yakuhin Kogyo CO., LTD (Japan).

Market Segmentation

Global Unnatural Amino Acids Market, by Type

• D-Amino Acids & Derivatives
  • D-Phenylalanine
  • D-Histidine
  • D-Tyrosine
  • D-Serine
  • D-Alanine
  • D-Tryptophan
  • D-Cysteine
  • D-Phenylglycine
  • D-p-hydroxy phenylglycine
  • D-2-Chlorophenylglycine
  • D-Penicillamine
  • D- Proline
  • D-Valine
  • Others
• DL-Amino Acids & Derivatives
  • DL-Phenylalanine
  • DL-Alanine
  • DL-Methionine
  • Others
  • β-Amino Acids & Derivatives
  • β-Amino acids
  • β-Alanine
  • β-methylphenylalanine
  • β-Amino Alcohols
  • Others
• Cyclic Amino Acids & Derivatives
  • Cyclic β-Amino Acids
  • Others
  • L-Amino Acid Derivatives
  • L-Dopa
  • L-Thyroxine
  • L-Homophenylalanine
  • Others
• Gamma-Amino Butyric Acid (GABA)
• Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB)
• Synthetic-Amino Acids
• Others

Global Unnatural Amino Acids Market, by Application

• Liver Diseases
• Cancer
• Inflammatory Disease
• Genetic Diseases
• Others

Global Unnatural Amino Acids Market, by End User

• Pharmaceutical & Biotechnological Companies
• Research Laboratories
• Academic Institutes
• Others